SE511524C2 - Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier - Google Patents

Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier

Info

Publication number
SE511524C2
SE511524C2 SE9702083A SE9702083A SE511524C2 SE 511524 C2 SE511524 C2 SE 511524C2 SE 9702083 A SE9702083 A SE 9702083A SE 9702083 A SE9702083 A SE 9702083A SE 511524 C2 SE511524 C2 SE 511524C2
Authority
SE
Sweden
Prior art keywords
pharmaceutical preparation
strain
preparation according
lactobacillus casei
lactobacillus
Prior art date
Application number
SE9702083A
Other languages
English (en)
Swedish (sv)
Other versions
SE9702083D0 (sv
SE9702083L (sv
Inventor
Haakansson Eva Grahn
Stellan Haakansson
Original Assignee
Essum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essum Ab filed Critical Essum Ab
Priority to SE9702083A priority Critical patent/SE511524C2/sv
Publication of SE9702083D0 publication Critical patent/SE9702083D0/xx
Priority to DE69831578T priority patent/DE69831578T2/de
Priority to DK98928734T priority patent/DK1005353T3/da
Priority to EP98928734A priority patent/EP1005353B1/de
Priority to CA002291623A priority patent/CA2291623A1/en
Priority to ES98928734T priority patent/ES2245801T3/es
Priority to AU80460/98A priority patent/AU726217B2/en
Priority to CNB988070170A priority patent/CN1153575C/zh
Priority to PCT/SE1998/001041 priority patent/WO1998055131A1/en
Priority to AT98928734T priority patent/ATE304366T1/de
Priority to JP50225399A priority patent/JP4350170B2/ja
Publication of SE9702083L publication Critical patent/SE9702083L/xx
Publication of SE511524C2 publication Critical patent/SE511524C2/sv
Priority to NO19995794A priority patent/NO326122B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
SE9702083A 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier SE511524C2 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9702083A SE511524C2 (sv) 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
JP50225399A JP4350170B2 (ja) 1997-06-02 1998-06-02 ラクトバチルス・カセイ・ラムノススを含む薬学的調製物
AU80460/98A AU726217B2 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
DK98928734T DK1005353T3 (da) 1997-06-02 1998-06-02 Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
EP98928734A EP1005353B1 (de) 1997-06-02 1998-06-02 Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
CA002291623A CA2291623A1 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
ES98928734T ES2245801T3 (es) 1997-06-02 1998-06-02 Preparacion farmaceutica que comprende lactobacillus casei rhamnosus.
DE69831578T DE69831578T2 (de) 1997-06-02 1998-06-02 Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
CNB988070170A CN1153575C (zh) 1997-06-02 1998-06-02 包含鼠李糖乳杆菌的药物制剂
PCT/SE1998/001041 WO1998055131A1 (en) 1997-06-02 1998-06-02 Pharmaceutical preparation comprising lactobacillus casei rhamnosus
AT98928734T ATE304366T1 (de) 1997-06-02 1998-06-02 Lactobacillus casei rhamnosus-haltige pharmazeutische formulierung
NO19995794A NO326122B1 (no) 1997-06-02 1999-11-26 Farmasoytisk preparat inneholdende "Lactobacillus casei rhamnosus"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702083A SE511524C2 (sv) 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier

Publications (3)

Publication Number Publication Date
SE9702083D0 SE9702083D0 (sv) 1997-06-02
SE9702083L SE9702083L (sv) 1998-12-03
SE511524C2 true SE511524C2 (sv) 1999-10-11

Family

ID=20407203

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702083A SE511524C2 (sv) 1997-06-02 1997-06-02 Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier

Country Status (12)

Country Link
EP (1) EP1005353B1 (de)
JP (1) JP4350170B2 (de)
CN (1) CN1153575C (de)
AT (1) ATE304366T1 (de)
AU (1) AU726217B2 (de)
CA (1) CA2291623A1 (de)
DE (1) DE69831578T2 (de)
DK (1) DK1005353T3 (de)
ES (1) ES2245801T3 (de)
NO (1) NO326122B1 (de)
SE (1) SE511524C2 (de)
WO (1) WO1998055131A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034787A1 (de) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
AU784898B2 (en) * 2000-01-18 2006-07-20 Societe Des Produits Nestle S.A. Pet food composition for treating helicobacter species in pets
FR2808689B1 (fr) 2000-05-11 2004-09-03 Agronomique Inst Nat Rech Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
CN1444484A (zh) * 2000-06-19 2003-09-24 穆科普罗泰科有限公司 用益生菌对粘膜表面的细菌或病毒感染进行治疗或免疫治疗及用于此的组合物
BR0006628A (pt) * 2000-12-07 2004-06-22 Sanab Saneamento Ambiental E B Sistema anaeróbico de tratamento de lixo urbano, resìduos agro-industrias e biomassa
WO2002045727A1 (en) * 2000-12-08 2002-06-13 Plbio Co., Ltd. Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa
KR100449597B1 (ko) * 2000-12-08 2004-09-18 (주) 피엘바이오 헬리코박터 필로리의 활성을 억제하는 유산균
KR100424790B1 (ko) * 2000-12-08 2004-03-30 (주) 피엘바이오 헬리코박터 필로리의 활성을 억제하는 유산균
AU7675601A (en) * 2000-12-08 2002-06-18 Pl Bio Co Ltd Lactic acid bacteria with inhibiting activities on (helicobacter pylori)
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
KR20040018319A (ko) * 2000-12-18 2004-03-03 프로비오헬쓰 엘엘씨 락토바실러스 카제이 균주 κε01에서 유래된 정장제 화합물
SG97174A1 (en) * 2000-12-19 2003-07-18 Cell Biotechnology Food Co Ltd Lactobacillus rhamnosus strain and uses thereof
WO2002055092A1 (fr) * 2001-01-16 2002-07-18 Amato Pharmaceutical Products,Ltd. Traitements preventifs et/ou remedes contre les maladies digestives
PT1570060E (pt) * 2002-12-02 2007-09-13 Basf Ag ''sistema de expressão indutível de l-ramnose''
WO2005085287A1 (en) 2004-03-03 2005-09-15 En-N-Tech, Inc. Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions
PT1996696T (pt) * 2006-03-17 2017-03-17 Probi Ab Estirpes de lactobacillus termoestáveis
WO2007108763A1 (en) * 2006-03-17 2007-09-27 Probac Ab Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
CN101173228B (zh) * 2006-11-01 2011-08-17 信谊药厂 新的乳酸杆菌菌株、药物组合物及其用途、以及制造方法
FR2928935B1 (fr) * 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2349295B8 (de) * 2008-11-17 2016-12-14 Winclove Holding B.V. Pharmazeutische zusammensetzungen mit einer kombination aus streptokokken- und laktobazillenstämmen
US20110223137A1 (en) * 2008-12-05 2011-09-15 Nestec S.A. Compositions for use in low-birth weight infants
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
EP2604123A1 (de) 2011-12-15 2013-06-19 Friesland Brands B.V. Verfahren und Ernährungszusammensetzung zur Behandlung von Durchfall
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
EP2923704B1 (de) 2012-11-16 2024-03-20 Asahi Group Holdings, Ltd. Mittel zur linderung einer stressbedingten darmerkrankung mit einem spezifischen lactobacillus-gasseri-stamm oder einem behandlungsprodukt daraus
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
AR103260A1 (es) 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
EP3400953A1 (de) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirinpolypeptid und immunmodulation
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
ME03487B (de) 2016-03-04 2020-01-20 4D Pharma Plc Zusammensetzungen mit bakteriellen blautia-stämmen zur behandlung von viszeraler überempfindlichkeit
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (de) 2017-05-24 2022-11-30 4D Pharma Research Limited Zusammensetzungen mit bakterienstamm
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
CN109182166B (zh) * 2018-08-27 2021-08-20 南昌大学 一株具有缓解便秘功效的鼠李糖乳杆菌及其应用
CN110295130A (zh) * 2019-07-29 2019-10-01 诺佰克（武汉）生物科技有限公司 一株鼠李糖乳杆菌及其应用
CN113088470A (zh) * 2021-04-14 2021-07-09 广东医科大学 一株鼠李糖乳杆菌L.rB16及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2421066A1 (de) * 1974-05-02 1976-03-25 Solco Basel Ag Bifidobakterien enthaltendes praeparat
AU624067B2 (en) * 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen

Also Published As

Publication number Publication date
ATE304366T1 (de) 2005-09-15
DK1005353T3 (da) 2005-10-03
SE9702083D0 (sv) 1997-06-02
WO1998055131A1 (en) 1998-12-10
AU726217B2 (en) 2000-11-02
CN1272791A (zh) 2000-11-08
NO326122B1 (no) 2008-09-29
DE69831578D1 (de) 2005-10-20
CA2291623A1 (en) 1998-12-10
DE69831578T2 (de) 2006-04-27
SE9702083L (sv) 1998-12-03
JP4350170B2 (ja) 2009-10-21
CN1153575C (zh) 2004-06-16
JP2002507200A (ja) 2002-03-05
NO995794L (no) 2000-01-31
NO995794D0 (no) 1999-11-26
EP1005353B1 (de) 2005-09-14
ES2245801T3 (es) 2006-01-16
EP1005353A1 (de) 2000-06-07
AU8046098A (en) 1998-12-21

Similar Documents

Publication Publication Date Title
SE511524C2 (sv) Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
Zhou et al. Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice
RU2316586C2 (ru) ПРОБИОТИЧЕСКИЕ ШТАММЫ Lactobacillus (ВАРИАНТЫ) И ИХ ПРИМЕНЕНИЕ
Lin Probiotics as functional foods
Wang et al. Effects of ingesting Lactobacillus-and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori
JP6587614B2 (ja) プロバイオティクスとしてのラクトバチルス属の菌株
NO316644B1 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
KR20040018319A (ko) 락토바실러스 카제이 균주 κε01에서 유래된 정장제 화합물
CA2689360A1 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
US11376289B2 (en) Composition and uses thereof
JP2002534113A5 (de)
JP2024503366A (ja) 菌株、組成物および使用方法
CA2702293C (en) Probiotics for use in relieving symptoms associated with gastrointestinal disorders
CN113215035A (zh) 长双歧杆菌和动物双歧杆菌的制备及其在抗衰老方面的应用
Mikelsaar et al. Human lactic acid microflora and its role in the welfare of the host
CN110892961B (zh) 一种含乳双歧杆菌bl-99的固体饮料及其应用
Park et al. Immunoenhancing effects of a new probiotic strain, Lactobacillus fermentum PL9005
US20190091270A1 (en) Probiotics for use in relieving symptoms associated with gastrointestinal disorders
Pachenari An investigation of the potential of selected strains of Bifidobacterium to colonise the gastrointestinal tract of mice
HK40042147A (en) Composition and uses thereof
HK1146914B (en) Pharmaceutical compositions comprising l. acidophilus and bifidobacterium lactis for use in the treatment of functional bowel disorder

Legal Events

Date Code Title Description
NUG Patent has lapsed
NUG Patent has lapsed